Literature DB >> 25108555

MicroRNA networks in regulatory T cells.

Xuehua Tang1, Ruijing Tang, Yujun Xu, Qingling Wang, Yayi Hou, Sunan Shen, Tingting Wang.   

Abstract

MicroRNAs (miRNAs) are small regulatory RNAs that bind directly to complementary sequences on target messenger RNA (mRNA) transcripts, resulting in translational repression and/or target mRNA degradation. MiRNAs have been proven to play critical roles on the development, differentiation, and function of immune cells. Regulatory T cells (Tregs) are of importance in maintaining immune homeostasis and self-tolerance. Although many transcription factors and cytokines are known to regulate Tregs, scientists began to focus on the role of noncoding RNA on the regulation of Treg cells. This review provides an overview of the entire microRNA network and specific miRNAs in the development, differentiation, and function of Tregs.

Mesh:

Substances:

Year:  2014        PMID: 25108555     DOI: 10.1007/s13105-014-0348-x

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  38 in total

1.  MicroRNA genes are transcribed by RNA polymerase II.

Authors:  Yoontae Lee; Minju Kim; Jinju Han; Kyu-Hyun Yeom; Sanghyuk Lee; Sung Hee Baek; V Narry Kim
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

Review 2.  Getting to the root of miRNA-mediated gene silencing.

Authors:  Ana Eulalio; Eric Huntzinger; Elisa Izaurralde
Journal:  Cell       Date:  2008-01-11       Impact factor: 41.582

3.  Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells.

Authors:  Susan Kohlhaas; Oliver A Garden; Cheryl Scudamore; Martin Turner; Klaus Okkenhaug; Elena Vigorito
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

4.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

5.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Authors:  Ye Zheng; Steven Z Josefowicz; Arnold Kas; Tin-Tin Chu; Marc A Gavin; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

6.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

7.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.

Authors:  Yuanjia Tang; Xiaobing Luo; Huijuan Cui; Xuming Ni; Min Yuan; Yanzhi Guo; Xinfang Huang; Haibo Zhou; Niek de Vries; Paul Peter Tak; Shunle Chen; Nan Shen
Journal:  Arthritis Rheum       Date:  2009-04

8.  Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses.

Authors:  Li-Fan Lu; Mark P Boldin; Ashutosh Chaudhry; Ling-Li Lin; Konstantin D Taganov; Toshikatsu Hanada; Akihiko Yoshimura; David Baltimore; Alexander Y Rudensky
Journal:  Cell       Date:  2010-09-17       Impact factor: 41.582

9.  miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression.

Authors:  Heiko F Stahl; Tanja Fauti; Nina Ullrich; Tobias Bopp; Jan Kubach; Werner Rust; Paul Labhart; Vassili Alexiadis; Christian Becker; Mathias Hafner; Andreas Weith; Martin C Lenter; Helmut Jonuleit; Edgar Schmitt; Detlev Mennerich
Journal:  PLoS One       Date:  2009-09-24       Impact factor: 3.240

10.  The miR-17 ∼ 92a cluster of microRNAs is required for the fitness of Foxp3+ regulatory T cells.

Authors:  Jarrod P J Skinner; Ashleigh A Keown; Mark M W Chong
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

View more
  8 in total

1.  miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency.

Authors:  Yunjie Lu; Keli L Hippen; Amanda L Lemire; Jian Gu; Weizhi Wang; Xuhao Ni; Parvathi Ranganathan; Bruce L Levine; James L Riley; Carl H June; Laurence A Turka; David H Munn; Ramiro Garzon; Ling Lu; Bruce R Blazar
Journal:  Blood       Date:  2016-08-02       Impact factor: 22.113

2.  miRNA-Processing Gene Methylation and Cancer Risk.

Authors:  Brian T Joyce; Yinan Zheng; Zhou Zhang; Lei Liu; Masha Kocherginsky; Robert Murphy; Chad J Achenbach; Jonah Musa; Firas Wehbe; Allan Just; Jincheng Shen; Pantel Vokonas; Joel Schwartz; Andrea A Baccarelli; Lifang Hou
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-02-23       Impact factor: 4.254

3.  Circulating Plasma microRNAs can differentiate Human Sepsis and Systemic Inflammatory Response Syndrome (SIRS).

Authors:  Stefano Caserta; Florian Kern; Jonathan Cohen; Stephen Drage; Sarah F Newbury; Martin J Llewelyn
Journal:  Sci Rep       Date:  2016-06-20       Impact factor: 4.379

Review 4.  New Insights into Regulatory T Cells: Exosome- and Non-Coding RNA-Mediated Regulation of Homeostasis and Resident Treg Cells.

Authors:  Peiyao Li; Changhong Liu; Zhibin Yu; Minghua Wu
Journal:  Front Immunol       Date:  2016-12-06       Impact factor: 7.561

Review 5.  Effects of MicroRNA on Regulatory T Cells and Implications for Adoptive Cellular Therapy to Ameliorate Graft-versus-Host Disease.

Authors:  Keli L Hippen; Michael Loschi; Jemma Nicholls; Kelli P A MacDonald; Bruce R Blazar
Journal:  Front Immunol       Date:  2018-01-31       Impact factor: 7.561

Review 6.  Circulating microRNAs as Potential Biomarkers of Infectious Disease.

Authors:  Carolina N Correia; Nicolas C Nalpas; Kirsten E McLoughlin; John A Browne; Stephen V Gordon; David E MacHugh; Ronan G Shaughnessy
Journal:  Front Immunol       Date:  2017-02-16       Impact factor: 7.561

Review 7.  Immune Regulation of Tissue Repair and Regeneration via miRNAs-New Therapeutic Target.

Authors:  Celeste Piotto; Ziad Julier; Mikaël M Martino
Journal:  Front Bioeng Biotechnol       Date:  2018-07-13

8.  MicroRNA expression profile in Treg cells in the course of primary immune thrombocytopenia.

Authors:  Yuandong Zhu; Huan Zhu; Xiaobao Xie; Zhuojun Zheng; Yun Ling
Journal:  J Investig Med       Date:  2019-07-03       Impact factor: 2.895

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.